Inopsin en es it fr

Inopsin Brand names, Inopsin Analogs

Inopsin Brand Names Mixture

  • No information avaliable

Inopsin Chemical_Formula


Inopsin RX_link

Inopsin fda sheet

Inopsin msds (material safety sheet)

Inopsin MSDS

Inopsin Synthesis Reference

No information avaliable

Inopsin Molecular Weight

166.24 g/mol

Inopsin Melting Point

No information avaliable

Inopsin H2O Solubility

Appreciable as liquid hydrochloride salt

Inopsin State


Inopsin LogP


Inopsin Dosage Forms

Liquid for injection

Inopsin Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Inopsin Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Inopsin Absorption

Rapidly absorbed.

Inopsin side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Inopsin Patient Information

No information avaliable

Inopsin Organisms Affected

Humans and other mammals